1. Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double‐blind, placebo‐controlled study. Issue 5 (26th December 2017) Authors: Fukudo, S.; Nakajima, A.; Fujiyama, Y.; Kosako, M.; Nakagawa, A.; Akiho, H.; Nakashima, Y.; Johnston, J. M.; Miwa, H. Journal: Neurogastroenterology & motility Issue: Volume 30:Issue 5(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Randomized, double‐blind, placebo‐controlled study vs data in the daily practice using linaclotide in patients with irritable bowel syndrome with constipation. Issue 5 (26th April 2018) Authors: Fukudo, S.; Nakajima, A.; Fujiyama, Y.; Kosako, M.; Nakagawa, A.; Akiho, H.; Nakashima, Y.; Johnston, J. M.; Miwa, H. Journal: Neurogastroenterology & motility Issue: Volume 30:Issue 5(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗